Results 141 to 150 of about 993 (170)

Pharmacoeconomics of medicines used for geriatric individuals in a tertiary care hospital in Delhi. [PDF]

Indian J Med Res
Singh VJ, Roy V, Singhal S, Daga MK.
europepmc   +1 more source

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors. [PDF]

Heliyon
Liu J, Yan S, Du J, Teng L, Yang R, Xu P, Tao W.   +6 more
europepmc   +1 more source

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [¹⁷⁷Lu]Lu-PP-F11N in humans: the lumed phase 0b study. [PDF]

EJNMMI Res
Rottenburger C, Hentschel M, Fürstner M, McDougall L, Kottoros D, Kaul F, Mansi R, Fani M, Vija AH, Schibli R, Geistlich S, Behe M, Christ ER, Wild D.   +13 more
europepmc   +1 more source

Intestinal Carriage of Two Distinct <i>stx_2f</i>-Carrying <i>Escherichia coli</i> Strains by a Child with Uncomplicated Diarrhea. [PDF]

Pathogens
Crombé F, van Hoek AHAM, Nailis H, Auvray F, Janssen T, Piérard D.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Racecadotril

Drugs, 2000
Racecadotril is an oral enkephalinase inhibitor used in the treatment of acute diarrhoea. It prevents the degradation of endogenous opioids (enkephalins), thereby reducing hypersecretion of water and electrolytes into the intestinal lumen. In a randomised double-blind study in 6 adult volunteers with castor oil-induced diarrhoea, racecadotril ...
Anna J. Matheson, Stuart Noble
  +8 more sources

Hypersensitivity to racecadotril: a case report

European Journal of Pediatrics, 2006
Hypersensitivity to racecadotril: a case ...
Nucera, Eleonora, Schiavino, Domenico, Altomonte, Giorgia, Buonomo, Alessandro, Sabato, Vito, Patriarca, Giampiero   +5 more
openaire   +4 more sources

REVIEW: Racecadotril Versus Loperamide: Antidiarrheal Research Revisited

Digestive Diseases and Sciences, 2003
Racecadotril is an enkephalinase inhibitor, presented as a purely antisecretory agent with advantages over the opiate-receptor agonist loperamide in the treatment of diarrhea. A critical review of the literature and the models used was performed. Although pretreatment with high doses of racecadotril reduced cholera toxin-induced secretion and although ...
F. Awouters, S. Huijghebaert, G.N.J. Tytgat   +2 more
openaire   +3 more sources

Racecadotril demonstrates intestinal antisecretory activity in vivo

Alimentary Pharmacology & Therapeutics, 1999
Background Racecadotril (acetorphan), a potent enkephalinase inhibitor, protects endogenous enkephalins from degradation. Racecadotril exhibits experimental and clinical antidiarrhoeal activity without any effect on intestinal motility, suggesting selective antisecretory activity.
Primi, M.P., Bueno, Lionel, Baumer, P., Berard, H., Lecomte, J.M.   +4 more
openaire   +4 more sources